CannActuality
Cannabis research for product development
CannActuality is a research platform for the licensed cannabis industry. We turn point-of-sale data, consumer research, and regulatory filings into clear, sourced briefs that guide product development for brands, manufacturers, and dispensaries — what to launch, in what format, at what strength, in which channel, and when the rules change underneath you.
Independent research & education for licensed vendors · Adults 21+ · CannActuality does not sell cannabis
What the research covers
A product roadmap fails when any one of these moves and nobody notices. CannActuality tracks all four, continuously, and publishes what changes.
Category sales, unit velocity, price movement, and format shifts from tracked retail data — which categories are growing, which are consolidating, and where consumers are trading down or trading up.
Deep dives on the formats where development money is moving: beverages, pre-rolls, edibles, vapes, and emerging cannabinoid profiles — strengths, pack architecture, flavor systems, and channel fit.
Dispensary, liquor, convenience, and grocery channels behave differently. Our briefs separate them, because a product tuned for one shelf routinely underperforms on another.
Federal and state rule changes — rescheduling, hemp redefinition, state integration laws, tax rates — translated into dated product decisions: reformulate, reposition, re-channel, or wait.
Latest briefs
Every brief is dated, sourced to the publisher and data behind each number, and written for the people who decide what gets built next.
Pre-rolls are America's top category by units. The 1-gram single still anchors volume, 0.5-gram five-packs drive growth, and infused has crossed half of category dollars — how to build the pack ladder.
Medical marijuana is Schedule III, broad rescheduling is stayed, and the federal hemp redefinition lands November 12 and December 11, 2026. What each date means for your roadmap.
Convenience-store hemp beverage sales grew 74% year over year and 10 mg became the leading strength. The development implications — and the December deadline hanging over the hemp channel.
Who it's for
How vendors use it
Each brief opens with the takeaways and the data behind them — no number appears without a named source and date.
Every brief closes with a product-development section: what to build, adjust, or stop — written for your next planning cycle.
Need your category, your state, your shelf? Request a custom brief scoped to your roadmap. See how →
Contact
Suggest a topic, request a custom brief, or tell us what your team is deciding:
Email: taugustincst@gmail.com
Or send a message right here — we reply by email: